See Also:
HWCI Research Associate Program
Submissions from 2026
Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial, Alessandro Villa
Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis, Manmeet Ahluwalia and Sarbajit Mukherjee
Signet ring cell carcinoma of the urachus: survival and pathologic outcomes from the national cancer database, Deerush Kannan Sakthivel, Pushan Prabhakar, Mohamed Javid Raja Iyub, Rohan Garje, and Murugesan Manoharan
Sociodemographic Factors and Treatment Patterns Associated with Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022), Mohammad Arfat Ganiyani
Special issue on Contemporary and emerging stereotactic radiosurgery and stereotactic body radiation therapy technology, Michael McDermott
Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of Prospective Trials, Rupesh Kotecha and Lili Zhou
Stereotactic radiosurgery using a self-shielded gyroscopic radiosurgery system for meningiomas: technical aspects and dosimetric results, Yongsook Lee, Rupesh Kotecha, Robert Press, Noah Kalman, Matthew Hall, D. Jay Wieczorek, Ranjini Tolakanahalli, Minesh Mehta, Michael McDermott, and Alonso Gutierrez
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary, Yuliya Linhares
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary, Yuliya Linhares
Survival and hematologic toxicity after whole-brain radiotherapy, photon craniospinal irradiation, and proton craniospinal irradiation for solid-tumor leptomeningeal disease: a systematic review, Mishaal Munir, Kavita Sehrawat, Matthew Hall, Minesh Mehta, and Rupesh Kotecha
Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study, Zouina Sarfraz, Lydia Hodgson, Arun Maharaj, Reshma Mahtani, and Manmeet Ahluwalia
The evolution of RTOG and NRG Oncology CNS tumors clinical trials, Kavita Sehrawat and Minesh Mehta
The global epidemiology of acute myeloid leukaemia, Firas El Chaer
The hematology workforce in the United States: past, present, and strategies for the future, Srikanth Nagalla
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients, Michael McDermott
The Miami Cancer Institute technique: Puboprostatic complex preserving dorsal venous complex ligation with cystourethropexy, Deerush Kannan Sakthivel, Pushan Prabhakar, Mohamed Javid Raja Iyub, Arjun Pon Avudaiappan, and Murugesan Manoharan
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0, Bruna Pellini
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1, Bruna Pellini
The Role of Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Carcinoma in the Era of Emerging Systemic Therapy: A Retrospective Cohort Study, Mohammad Arfat Ganiyani, Arjun Pon Avudaiappan, Mohamed Javid Raja Iyub, Murugesan Manoharan, and Rohan Garje
Three-Arm Versus Four-Arm Configurations in Robot-Assisted Partial Nephrectomy: A Systematic Review and Meta-Analysis, Mohamed Javid Raja Iyub, Pushan Prabhakar, Deerush Kannan Sakthivel, Manuel Ozambela, and Murugesan Manoharan
Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation Therapy, Sreenija Yarlagadda, Arun Maharaj, Andrea Gonzalez, NaimaSajoni Guerra, Dylan Paterniti-Ruscin, Elysse Castro-Hall, Lorein Gonzalez, Muni Rubens, Noah Kalman, and Adeel Kaiser
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab, Sarbajit Mukherjee
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab, Sarbajit Mukherjee